diazooxonorleucine and Adenocarcinoma

diazooxonorleucine has been researched along with Adenocarcinoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
DueƱas-Gonzalez, A; Schcolnik-Cabrera, A1
Anand, SK; Beer, DG; Carskadon, SL; Chakravarthi, BV; Chen, G; Chinnaiyan, AM; Giordano, TJ; Goswami, MT; Palanisamy, N; Pathi, SS; Thomas, DG; Varambally, S1
Arakawa, M; Ardalan, B; Cooney, DA; Jayaram, H; Villacorte, D1
Creagan, ET; Eagan, RT; Frytak, S; Ingle, JN; Nichols, WC1
Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; Sorensen, S; van Hazel, GA1
Casper, ES; Magill, GB; Sklaroff, RB; Young, CW1

Other Studies

7 other study(ies) available for diazooxonorleucine and Adenocarcinoma

ArticleYear
Mouse Model for Efficient Simultaneous Targeting of Glycolysis, Glutaminolysis, and De Novo Synthesis of Fatty Acids in Colon Cancer.
    Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2174

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Diazooxonorleucine; Drug Screening Assays, Antitumor; Fatty Acid Synthase, Type I; Fatty Acids; Female; Glutaminase; Glutamine; Glycolysis; Hexokinase; Indazoles; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Orlistat; Smegmamorpha

2021
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
    Oncotarget, 2015, Sep-15, Volume: 6, Issue:27

    Topics: Adenocarcinoma; Aged; Amidophosphoribosyltransferase; Aneuploidy; Animals; Biomarkers, Tumor; Carboxy-Lyases; Cell Line, Tumor; Cell Proliferation; Chickens; Diazooxonorleucine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Peptide Synthases; Prognosis; Purines

2015
Hypercalcemia of malignant disease.
    California medicine, 1967, Volume: 107, Issue:1

    Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Breast Neoplasms; Diazooxonorleucine; Female; Humans; Hyperkalemia; Lung Neoplasms; Male; Rats

1967
Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
    Biochemical pharmacology, 1982, Apr-15, Volume: 31, Issue:8

    Topics: Adenocarcinoma; Animals; Azaserine; Colonic Neoplasms; Diazooxonorleucine; Glutamine; Intestine, Small; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Neoplasms, Experimental; Pentosephosphates; Phosphoribosyl Pyrophosphate

1982
Phase II study on DON in patients with previously treated advanced lung cancer.
    Cancer treatment reports, 1982, Volume: 66, Issue:8

    Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Azo Compounds; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diazooxonorleucine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis

1982
A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma.
    American journal of clinical oncology, 1983, Volume: 6, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Azo Compounds; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Rectal Neoplasms; Vomiting

1983
Phase I study of 6-diazo-5-oxo-L-norleucine (DON).
    Cancer treatment reports, 1980, Volume: 64, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azo Compounds; Bone Marrow; Carcinoma, Squamous Cell; Diazooxonorleucine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting

1980